Three cases of facial erythema with dryness and pruritus in psoriasis patients during treatment with IL-17 inhibitors

β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis

(2017) Frank Kolbinger et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation

(2017) Achilleas Floudas et al.   JOURNAL OF IMMUNOLOGY

T H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma

(2015) David F. Choy et al.   Science Translational Medicine

Immunology of Psoriasis

(2014) Michelle A. Lowes et al.   Annual Review of Immunology

New concept of the pathogenesis of atopic dermatitis: Interplay among the barrier, allergy, and pruritus as a trinity

(2013) Kenji Kabashima   JOURNAL OF DERMATOLOGICAL SCIENCE

Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy

(2012) Anna R Huppler et al.   ARTHRITIS RESEARCH & THERAPY